Generic Qvar Inhaler (Beclate Inhaler)

Generic Qvar Inhaler (Beclate Inhaler) is used to prevent wheezing, shortness of breath, coughing, and chest tightness caused by asthma and other lung diseases in patients 5 years of age and older. It is also used in the maintenance treatment of asthma as well as for asthma patients who require systemic corticosteroid administration in order to reduce or eliminate the need for the systemic corticosteroids.

Chemical Structure

The active pharmaceutical ingredient contained in Generic Qvar Inhaler (Beclate Inhaler) is Beclomethasone Dipropionate. Beclate Inhaler contains Beclomethasone Dipropionate 100 mcg or 200 mcg suspended in CFC-free propellant. Beclate Inhaler contains 200 metered doses. The amount of medicine in each puff of Beclate 100 Inhaler is 100 micrograms of Beclomethasone Dipropionate, and 200 micrograms in each puff of Beclate 200 Inhaler.

Active Ingredient

The other medications that have the same active pharmaceutical ingredient (Beclomethasone Dipropionate) contained in Generic Qvar Inhaler (Beclate Inhaler) are Beclovent Inhaler, Vanceril, Asmabec Clickhaler, Clenil Modulite and Easyhaler Beclometasone Dipropionate.

Similar Medications

Asthma Prophylaxis: Adults and Adolescents (12 years and older):The starting dose is 600-800 mcg/day in divided doses.

Mild to Moderate Asthma:Adults and Adolescents (12 years and older):

Starting and maintenance dose for mild to moderate Asthma is 50 to 200 mcg twice daily. In more severe cases, doses up to 400 mcg twice daily may be used. The maximum recommended daily dose is 800 mcg, although dosages of upto 250 mcg 4 times/day with a maximum of 2 mg/day may be prescribed for severe Asthma.

Recommended Dosage

Nasal Allergic and Non-Allergic Rhinitis: Adults and Adolescents (12 years and older):100 mcg into each nostril twice daily. Max: 400 mcg/day.

Recommended Dosage

Contraindications

Generic Qvar Inhaler (Beclate Inhaler) is contraindicated in patients with the following conditions:

Hypersensitivity to Beclomethasone Dipropionate, or any inactive component of this medication.

Side Effects of Generic Qvar Inhaler

Inform your doctor if you notice and are worried by any of the following side effects:Sore, creamy-yellow raised patches in the mouth (thrush), or a hoarse voice. These problems are less likely to occur if you rinse your mouth out with water each time after using Generic Qvar Inhaler. If thrush does occur, you can use a topical anti fungal therapy while continuing treatment with Generic Qvar Inhaler (Beclate Inhaler).

Side Effects of Generic Qvar Inhaler

Inform your doctor if you notice and are worried by any of the following side effects:Narrowing of the airways, or chest tightness. This may happen if your lungs are very sensitive. If this occurs use a reliever inhaler. You may also prevent this effect by using your reliever inhaler before using your Generic Qvar Inhaler. If this effect is severe, stop using Generic Qvar Inhaler (Beclate Inhaler) and see your doctor immediately.

Side Effects of Generic Qvar Inhaler

Inform your doctor if you notice and are worried by any of the following side effects:Allergic reactions such as rashes, itching, redness and swelling of the lips, mouth, throat and eyes may occur. If you experience any of these side effects you should see your doctor as soon as possible

Warnings And Precautions

Generic Qvar Inhaler is not indicated for immediate relief of asthma attacks or status asthmaticus. Patients should be made aware of the prophylactic nature of treatment with inhaled beclomethasone and that it should be taken regularly, even when they are asymptomatic.

Inhaled corticosteroids are designed to direct glucocorticoid activity to the lungs in order to reduce the overall systemic glucocorticoid exposure and side effects. In sufficient doses, however, all inhaled corticosteroids can have adverse effects, notably depression of the hypothalamic-pituitary-adrenal (HPA) axis, reduction of bone density and retardation of growth in children.

Warnings And Precautions

Patients who have received systemic corticosteroids for long periods of time or at high doses, or both, need special care and subsequent management when being transferred to inhaled corticosteroid therapy.

In patients who have been transferred from oral corticosteroids to inhalation therapy, systemic therapy may need to be reinstated during periods of stress or where airways obstruction or mucus prevents absorption by inhalation.

Discontinuation of systemic corticosteroids may cause exacerbation of allergic diseases such as atopic eczema and rhinitis. These should be treated as required with appropriate therapy

Warnings And Precautions

There is no experience of Generic Qvar in pregnancy in humans; therefore the product should only be used if the benefits outweigh any potential risk to the patient.

There is no experience of Generic Qvar product in lactation in humans; therefore the product should only be used if the benefits outweigh any potential risk to the patient.

Overdose Symptoms And Treatment

Acute overdose is unlikely to cause problems. The only harmful effect that follows inhalation of large amounts of beclomethasone over a short time period is suppression of HPA function. Specific emergency action need not be taken. Treatment with Generic Qvar Inhaler (Beclate Inhaler) should be continued at the recommended dose to control the asthma and HPA function can be expected to recover in a day or two.

Overdose Symptoms And Treatment

If very large and excessive doses of Beclomethasone were taken over a prolonged period a degree of atrophy of the adrenal cortex could occur in addition to HPA suppression. In this event the patient should be treated as corticosteroid dependent and transferred to a suitable maintenance dose of a systemic corticosteroid such as prednisone. Once the condition is stabilised, the patient should be transferred to Beclate Inhaler at the recommended doses.

Beclate Inhaler Manufactured by Cipla Ltd.

For more information click here

Generic Qvar Inhaler

The Swiss Pharmacy, Geneva Switzerland